Scotts Miracle-Gro (SMG) Tops Q4 EPS by 3c, Beats on Revenues; FY18 EPS Outlook Below Consensus

Go back to Scotts Miracle-Gro (SMG) Tops Q4 EPS by 3c, Beats on Revenues; FY18 EPS Outlook Below Consensus

JPMorgan Downgrades Scotts Miracle-Gro (SMG) to Neutral

November 8, 2017 4:32 AM EST

JPMorgan downgraded Scotts Miracle-Gro (NYSE: SMG) from Overweight to Neutral with a price target of $99.00 (from $98.00).

Analyst Jeff Zekauskas believes the equity is fairly valued as it purchases assets in the cannabis market and impacts free cash flow levels to a... More